Our research also focuses on better understanding the cellular and molecular mechanisms underlying cardiovascular diseases and congenital disease-related heart failure such as spinal muscular atrophy (SMA).   For that purpose, we use animal models that closely mimic human cardiovascular/atherosclerotic conditions or cellular models including patient-derived induced pluripotent stem cells (iPSCs).